LCRF Research Grant on Understanding Resistance in Lung Cancer

This grant mechanism will focus on understanding the development, prevention, and therapy of resistance by supporting projects that are identifying, characterizing, treating or preventing resistance to therapies in lung tumor cells, tissues, mouse models, and/or patients. Areas of interest include:  

• Mechanisms of resistance to targeted therapies for oncogene-driven lung cancers including, but not limited to (ALK+, EGFR, KRAS and MET)
• Biology and mechanisms of drug resistance to lung cancer therapies i.e. chemotherapy, immunotherapy and radiotherapy
• Novel treatment approaches and new therapies to overcome and/or prevent resistance to lung cancer therapies
• Novel diagnostic approaches to monitor treatment response and relapse

Funding: $150,000
Duration: 2 years

Research Authority deadline: 2.3.23

LOI (required) due date: 10.3.23

Full proposal due date: 31.5.23